» I agree with Hairsite.
»
» There are to many crazies on this board, just because people didn’t get
» the results/information they wanted from ICX, when they wanted, they throw
» their toys out of the pram and cry and moan about it “failing”. Which is
» not the case at present.
With regard to people crying that ICX said small scale commercialization would be here in 2008/09, that was a best case scenario prediction. Since this prediction was made the MHRA ruled TRC as a drug, so it now has to go through all three phases.
ICX looking for a partner for TRC in phase III is completely normal and if you keep up to date with ICX, it has been their plan for at least 1-2 years now, it was not a spur of the moment “aaah were failing lets get rid!” thing.
(Partnering with the likes of Bosley {A huge HT company, that have more advertisement/marketing ability/money than ICX} ties in nicely with ICX prediction that their current best possible results would work best as a filler for a transplant.)
ICX have stated what results they are expecting to get from TRC, and it’s a hell of a lot less that the expectations of about 99% of the people on this board.
There not aiming for 100% complete and natural density, they are aiming for something that would be a filler for a HT (which wouldn’t be that bad, think double the grafts).
ICX knows its protocol for TRC in not perfect and are aiming for results within their technological boundaries.
This information has been given by ICX.
I wouldn’t be surprised if we see TRC on the market within 7-10 years with mediocre results.
I for one don’t even care about ICX-TRC anymore (It would be nice if we got it) but I’m more hopeful for Folica, I completely disagree with debris theory about folica’s method and I feel much more confident in the opinions of the people behind it.
Even if folica does have to go through III phases of clinical trials, it won’t take 10-15 years, because everything is approved for other uses so it won’t need the full whack of safety/efficacy trials as something like TRC would.
Anyway I’m sure they won’t need to go through these kind of trials but they would need some kind of over all review after 1-2 years of their testing.
(Who knows, they may go through 1 year of trials like they plan, get denied by the FDA and have to go through III phases and another review, which would be a buzz kill.)
I’m confident though in the opinions in the people behind folica that it won’t need III stages of clinical trial but a small trial and then review. And no debris, im not a desperate bald guy